About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Drug for Hepatitis C to be Launched in India by Gilead Sciences

by Julia Samuel on January 27, 2015 at 12:59 PM
Font : A-A+

Drug for Hepatitis C to be Launched in India by Gilead Sciences

Gilead Sciences Inc. aims to launch Sovaldi, the hepatitis C drug, in India by June and to expand the reach of a generic licensing agreement with Indian drug-makers to include an investigational combination pill.

The pill could treat six genotypes of hepatitis C if approved by regulators and is a combination of sofosbuvir, the chemical name for Sovaldi, with GS-5816, a compound in advanced clinical trials in the U.S.

Advertisement

Gregg Alton, an executive vice president at the Foster City, California-based company, said, "Gilead will ask India's health ministry to waive clinical trials and expedite approval for the compound, which eliminates the need for costly genotype tests".

"In many of the resource limited environments around the world, it's very difficult, and not feasible to do genotyping. It's an expensive diagnostic that's simply not available many places" Alton said.
Advertisement

Gilead's Sovaldi, which will launch at $900 for a 12-week regimen in India, has drawn criticism from patient advocates in developing countries, who say that its generic licensing agreement doesn't cover enough of the middle-income countries with high hepatitis C burdens.

The investigational fixed dose combination pill that's been added to the licenses could be a more cost effective way of treating hepatitis C in poor countries, Alton said.

Gilead Sciences has licensed eight India-based generic drugmakers to bring cheaper versions of Sovaldi to 91 mainly low-income countries, including India, Indonesia, Cambodia and many nations in Africa.

Source: Medindia
Advertisement
Advertisement
Advertisement

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Drug for Hepatitis C to be Launched in India by Gilead Sciences Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests